Page 4 - Johan Dighed News Today

Investegate announcements from Karolinska Development AB (pub, Karolinska Development’s portfolio company Promimic’s stock starts trading today

STOCKHOLM, Sweden, April 29 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Promimic's stock starts trading today at Nasdaq First North Growth Market. The

STOCKHOLM, Sweden, April 29 2022. Karolinska Development AB announces that its portfolio company Promimic’s stock starts trading today at Nasdaq First North Growth Market. The shares will be... | April 29, 2022

STOCKHOLM, SWEDEN, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has enrolled all patients in the clinical study TOP FUSION, which

STOCKHOLM, Sweden, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic's IPO offering was fully subscribed. Promimic is now provided with

Investegate announcements from Karolinska Development AB (pub, Karolinska Developments portfolio company AnaCardio raises SEK 33 million to progress clinical development of a novel therapy for heart failure

STOCKHOLM, SWEDEN February 3, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has completed a fundraising of SEK 33 million comprised of a

STOCKHOLM, SWEDEN 11 January 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Svenska Vaccinfabriken has appointed Richard Bethell as new CEO. He will

STOCKHOLM, SWEDEN - 11 January 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has presented results from a preclinical study showing

STOCKHOLM SWEDEN - December 13, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the previously announced transaction, in which the global pharmaceutical company Organon &